Regenerative Medicine

Results: 756



#Item
441Microsoft Word - BroadNewLabsNR _2_.doc

Microsoft Word - BroadNewLabsNR _2_.doc

Add to Reading List

Source URL: broadmedical.org

Language: English - Date: 2010-10-29 13:06:21
442VistaGen  Therapeutics  Becomes  Member  of   Centre  for  Commercialization  of  Regenerative  Medicine  (CCRM)  Consortium     SOUTH   SAN   FRANCISCO,   CA   –

VistaGen  Therapeutics  Becomes  Member  of   Centre  for  Commercialization  of  Regenerative  Medicine  (CCRM)  Consortium     SOUTH   SAN   FRANCISCO,   CA   –

Add to Reading List

Source URL: www.ccrm.ca

Language: English - Date: 2012-12-06 13:14:14
443Hemostemix  Joins  Centre  for  Commercialization  of  Regenerative  Medicine,   Industry  Consortium   CCRM  and  Hemostemix  to  Partner  on  Development  of  Cell

Hemostemix  Joins  Centre  for  Commercialization  of  Regenerative  Medicine,   Industry  Consortium   CCRM  and  Hemostemix  to  Partner  on  Development  of  Cell

Add to Reading List

Source URL: ccrm.ca

Language: English - Date: 2014-07-18 13:43:40
444Using Regulatory T Cells to Protect the Kidney Biosciences and Health University of Virginia Department of Medicine Division of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine Gilbert R. Kinsey

Using Regulatory T Cells to Protect the Kidney Biosciences and Health University of Virginia Department of Medicine Division of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine Gilbert R. Kinsey

Add to Reading List

Source URL: www.virginia.edu

Language: English - Date: 2011-03-16 13:41:28
445California’s Stem Cell Agency CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE CIRM  is  spearheading  California’s  global  leadership  in  stem  cell  research  by  accelerating  

California’s Stem Cell Agency CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE CIRM  is  spearheading  California’s  global  leadership  in  stem  cell  research  by  accelerating  

Add to Reading List

Source URL: www.cirm.ca.gov

Language: English - Date: 2013-01-11 11:37:42
446Notice
To
RFP
Respondents
 PUBLIC
RELEASE
OF
PROPOSALS
 
 Under the California Public Records Act, the records of state agencies are generally available to the public upon request. The Proposal you subm

Notice
To
RFP
Respondents
 PUBLIC
RELEASE
OF
PROPOSALS
 
 Under the California Public Records Act, the records of state agencies are generally available to the public upon request. The Proposal you subm

Add to Reading List

Source URL: www.cirm.ca.gov

Language: English - Date: 2014-06-30 13:05:24
447Coverage, Cost-Control Mechanisms, and Financial Risk-Sharing Alternatives of High-Cost Health Care Technologies for California Institute for Regenerative Medicine by Brent D. Fulton, Ph.D.*

Coverage, Cost-Control Mechanisms, and Financial Risk-Sharing Alternatives of High-Cost Health Care Technologies for California Institute for Regenerative Medicine by Brent D. Fulton, Ph.D.*

Add to Reading List

Source URL: www.cirm.ca.gov

Language: English - Date: 2011-10-27 18:18:59
448Hemostemix  Joins  Centre  for  Commercialization  of  Regenerative  Medicine,   Industry  Consortium   CCRM  and  Hemostemix  to  Partner  on  Development  of  Cell

Hemostemix  Joins  Centre  for  Commercialization  of  Regenerative  Medicine,   Industry  Consortium   CCRM  and  Hemostemix  to  Partner  on  Development  of  Cell

Add to Reading List

Source URL: www.ccrm.ca

Language: English - Date: 2014-07-18 13:43:40
449ANNUAL REPORT[removed]Enhanced Programming Creates New Opportunities “We’ve had a wonderful year of growth on multiple fronts, all made possible through collaboration. Our most exciting exchanges are with the clin

ANNUAL REPORT[removed]Enhanced Programming Creates New Opportunities “We’ve had a wonderful year of growth on multiple fronts, all made possible through collaboration. Our most exciting exchanges are with the clin

Add to Reading List

Source URL: www.ontariostemcell.ca

Language: English - Date: 2013-08-08 15:17:22
450Investing in translational research to produce clinical, commercial and financial outcomes: Current and future mechanisms A White Paper for CIRM by Steve Dickman and the team at CBT Advisors

Investing in translational research to produce clinical, commercial and financial outcomes: Current and future mechanisms A White Paper for CIRM by Steve Dickman and the team at CBT Advisors

Add to Reading List

Source URL: www.cirm.ca.gov

Language: English - Date: 2013-12-02 15:02:50